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Nutritional factors affect the incidence, severity of symptoms and 
progression of multiple sclerosis (MS). However, the role of specific 
nutritional factors remains largely unknown in MS. We conducted 
this hospital-based case-controlled study to investigate the association 
between dietary intake and risk of MS.
Materials & Methods
This study was conducted on 93 MS patients and 94 age-matched 
controls from Oct 2015 to Sep 2016 in Tehran, Iran. MS was 
diagnosed based on 2010 McDonald criteria and Brain Magnetic 
Resonance Imaging. Dietary intake was assessed using a validated 
semi-quantitative food frequency questionnaire. Odds ratio and 95% 
confidence interval of MS was calculated in different food groups 
using multiple logistic regression models adjusted for potentially 
confounding variables and compared between the two groups. 
Results
There was no significant difference between the age (34.62 ±9.68 
vs. 33.96±8.75) and BMI (23.96 ±4.07 vs. 24.47 ±4.07) of MS and 
control group, respectively. Higher intake of processed meat (OR 
(95% CI))=(2.07(1.18-3.63) and non-processed meat (1.38(1.13-
1.68)) were found in the MS group compared with the control. 
Conclusion
Higher intake of processed meat and non-processed meat was 
associated with increased risk of MS. Further studies on the probable 
role of these nutritional factors in the pathogenesis of MS are 
suggested.
Keywords: Multiple sclerosis; Diet; Food frequency questionnaire; 
Nutrition; Meat; Case-control study
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Introduction
Multiple sclerosis (MS) is a neurodegenerative 
disease of the central nervous system, with an 
autoimmune inflammatory process leading to 
blood-brain barrier disruption, perivascular 
inflammation, demyelination, axonal damage, 
and progressive neuronal loss. Precise etiology of 
MS is not clearly identified yet, though immune 
dysregulation due to genetic susceptibility and 
multiple environmental factors might have a role (1, 
2). Inflammatory and neurodegenerative processes 
are the two factors defining the course of the disease 
and the clinical phenotype. MS has been classified 
into four clinical subtypes: relapsing-remitting, 
progressive relapsing, primary progressive 
and secondary progressive. Lately, this classic 
description has been redefined in accordance with 
the disease activity and the clinical progression 
of the disease (2). The neurodegenerative disease 
disables patients with a wide range of chronic 
symptoms including impairment in mobility, 
sensory function, vision, cognition, bowel/bladder 
function, spasticity, pain, fatigue, depression, and 
tremor/coordination domains (3). Genetics, altered 
immune system and other environmental factors 
(infection and nutrition) might have a role on 
etiology of MS, though the exact etiology of the 
disease is still unknown (4). There is a geographical 
variation in MS incidence shown that risk of MS 
varies with migration in childhood, emphasizing 
on environmental factors as a risk factor for MS.  
Nutritional factors have an effect on incidence 
and severity of MS. However, the exact role of 
specific nutritional factors is not known yet (5). 
Higher intake of vitamin D has been correlated 
with decreased incidence of MS as shown in 
epidemiological studies (6). A considerable 
number of controlled clinical trials have failed to be 
conclusive on the role of diet in MS mainly due to 
limitations of study design, patient characteristics 
and the number of samples (7). 
There is an increasing incidence of MS in Tehran, 
Iran, and the prevalence was reported as high as 
74 in 100,000 in 2013 (8). “Lifetime use of dietary 
intervention was reported by 41% of people with 
MS in a study from Germany” (9). At present, no 
dietary guidelines are available for MS patients 
and individuals at risk. Associated studies have 
been focusing on the role of vitamin D and obesity 
that are both diet-dependent (10, 11).
There are considerable number of MS patients 
using dietary interventions and many diet-related 
comorbidities such as malnutrition, metabolic 
syndrome, and cardiovascular disease, seem to 
diminish the quality of life in MS patients. Thus, 
there is a need to evaluate the role of diet in MS 
with evidence-based methods in order to further 
provide an appropriate nutritional counselling to 
MS patients (12).
In a current case-control study, we examined the 
association between consumption of different 
food-group intake and the risk of MS and compared 
the macro and micro-nutrient intake between MS 
patients and healthy controls in Tehran
Materials & Methods
Participants and Study design
Participants were enrolled in this case-control 
study of 93 consecutive patients with MS and 94 
healthy subjects, group matched for age (years) 
and sex (male/female) in Tehran, Iran. Participants 
were recruited among patients aged 18-56 yr 
referred to Imam Hossein Hospital, Tehran, Iran 
from Oct 2015 to Sep 2016. MS was diagnosed 
by neurologist based on 2010 McDonald criteria 
and Brain Magnetic resonance imaging (13, 14). 
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The control group was formed by 94 sex- and age-
matched healthy individuals accompanying the 
patients in same hospital. 
Our inclusion criteria were an age limit of 18 to 70 
yr, MS diagnosed based on 2010 McDonald criteria 
and Brain MRI, having no diet modification since 
the start of course of the disease, having no other 
systemic disease, nonsmoker, taking no additional 
supplements before starting the course of the 
disease. Patients leaving more than 10 food items of 
questionnaire blank or having a total energy intake 
less than 800 Kcal or more than 4200 Kcal were 
excluded (15). The final study sample included 87 
cases and 87 controls after applying the exclusion 
criteria (Figure 1). 
The study was approved by the medical research 
Ethics Committee of Shahid Beheshti University 
of Medical Sciences. Written informed consent 
was obtained from all study participants. 
Assessment of dietary intake
We interviewed all the MS patients and control 
subjects using structured pretested questionnaires. 
The demographic characteristics (age (years), sex 
(male/female), BMI (kg/m2)), disease duration, 
Vitamin D supplementation before the onset of 
disease, family history of MS and the climate 
zone of the city they lived in the first 15 years of 
their life based on world map of Koppen-Geiger 
for climate in a demographic questionnaire dietary 
intake were noted (16). The FFQ contained a 
checklist of food items with a standard serving 
size regularly used by Iranians. Reliability of the 
questionnaire was confirmed by a previous study 
reported by Shahid Beheshti Endocrine Research 
Institute (17). Participants were asked to address 
their frequency of consumption of a given serving 
of each food item during the previous year on a 
daily, weekly or monthly assumption. The stated 
frequency of consumption of food items was then 
converted to daily intake. While using household 
measures, portion sizes of consumed foods were 
converted to grams. Nutrient consumption was 
then calculated using the Nutrients Composition 
of Iranian Foods Supplemented with the United 
States Department of Agriculture (USDA) Food 
Composition Data (18).
Statistical methods
The SPSS software ver. 18 (SPSS Inc., Chicago, IL, 
USA) was used for all statistical analyses. Normality 
of the distributions of dietary intake variables was 
assessed by the Kolmogorov-Smirnov test. Means 
and standard deviations were calculated for energy 
and all food items and nutrient intakes from FFQ. 
Energy-adjusted nutrient intakes were calculated to 
remove variation due to energy, using the residual 
method (19). For data with normal distribution the 
independent sample t-test and for data not normally 
distributed, the Mann-Whitney test was conducted 
to compare differences between the mean dietary 
intake of micronutrients between the two groups of 
MS patients and healthy controls. We also divided 
food items into 13 food groups including grains, 
total dairy, legumes, meat, processed meat, total 
vegetables, starchy vegetables, fruits, nuts, sugars, 
oil, salty snacks and sweet snacks. The food groups 
were then analyzed both as a continuous variable 
and as a categorical variable. Odds Ratio and 
95% Confidence interval for the risk of MS were 
estimated using logistic regression models adjusted 
for age, sex, BMI, family history of MS, Vitamin 
D supplementation before the onset of disease and 
the temperature zone they lived in the first 15 years 
of their life, total energy intake, total fiber and total 
fat.
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Results
This study was conducted on 93 MS patients and 94 
in the control group. The mean age of participants 
was mean ±SD =34.6±9.6 yr in MS and 34.9±8.7 
yr in controls and their mean BMI was 23.4±4.0 
kg/m2 in MS patients and 24.4 ±3.8 kg/m2 in 
controls. Mean total calorie intake was 2631+724 
kcal in MS and 2683±680 kcal in controls. Percent 
of male gender was 16% in MS patients and 19% 
in controls. The family history of MS was higher 
among MS patients (12%) than the controls (5%) 
(Table 1). There was no significant difference in 
intake of total energy, total carbohydrate, total 
protein and total fat between MS and control group 
but the MS patients had a significantly lower intake 
of total fibers (P=0.024) (Table 2). There was a 
significantly lower intake of sodium (7820±1274 
mg/day vs 8395±1592 mg/day) (P=0.03) and 
lycopene (6310± 2651 µg/day vs. 7615± 2712 
µg/day) (P=0.02) in MS patients compared to the 
control group. 
Mean intake of food groups and OR and 95% 
CI for the risk of MS are shown in Tables 3 and 
4. After adjustment for potential confounding 
variables, results obtained from modeling food 
groups as a continuous variable in relation to the 
risk of MS showed that the intake of processed 
meat (OR=2.07; 95% CI=1.18-3.63), and non-
processed meat (1.38; 1.13-1.68), increased the 
risk of MS. In this study, processed meat group 
was consisted of packaged tuna fish, sausage, 
hamburger and ham. Non-processed meat group 
consisted of beef, lamb, veal, chicken and fish 
meat. No significant difference between the intake 
of other food groups and risk of MS was observed. 
Although the P-value of sweet snacks and starchy 
vegetables were significant (Table 3), the OR and 
CI did not confirm a positive correlation (Table 4).






Age (years, mean ± SD) 34.62± 9.8 34.96± 8.75 0.64
Male (percent) 16% 19% _
BMI (Kg/m2 mean± SD) 23.46± 4.07 24.47± 3.81 0.12
Disease duration (years) 7.34± 6.1 _ _
Positive family history of MS (percent) 12% 5% _
Climate classification of location* (percent) 
Arid (Dessert-hot arid) 3% 1% _
Warm temperate (steppe-hot summer/dessert-warm summer) 11% 41% _
Snow (Steppe-warm summer) 85% 57% _
Vitamin D supplementation before disease onset 0.05% 0% _
MS subtype:
Relapsing-remitting ms 40% _ _
Progressive relapsing ms 17.50% _ _
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Clinically isolated syndrome 12.50% _ _
Secondary progressive ms 7.50% _ _
*Climate of the city they lived in first 15 years of life based on World Map of the Köppen-Geiger climate 
classification. The percentage of MS cases living in lower temperature zone (steppe warm -summer) 
was higher than control group (85% vs 57%). The MS subtype of participants Included: 40% Relapsing-
Remitting, 17.50% Progressive Relapsing, 12.50% Clinically Isolated Syndrome and 7.50% Secondary 
Progressive MS.
Table 2. Dietary intake of the study participants*
  MS”  Control”  P-value  
Energy (Kcal) 2631±724 2683±680 0.31
Carbohydrate(g) 772±116 762± 99 0.55
Total fat(g) 191±31.9 199±31.1 0.14
Protein(g) 175±27.2 179±26.4 0.24
Total fiber(g) 90±20 93±21 0.024
Data are mean ± standard deviation 
*Mean daily intake of energy, macronutrients and fiber were compared between MS and control using 
independent sample T-test
Table 3. Dietary intake of the study participants*
  MS  Control P-value
Grains 534.51±371.25 508.87±179.11 0.31
Total Dairy 499.44±435.49 355.93±231.93 0.19
Legumes 51.98±69.84 50.28±55.04 0.42
Meat (non-processed) 67.2±78.32 77.62±52.44 0.01
Processed Meat 9.66±12.86 16.38±22.76 0.01
Total Vegetables 341.95±257.19 400.28±243.81 0.14
Starchy vegetables 37.38±27.08 43.33±31.98 0.009
Fruits 491.18±369.27 474.55±371.86 0.88
Nuts 29.93±127.14 15.14±21.44 0.65
Sugars 152.55±23.24 151.73±23.24 0.27
Oils 36.42±31.13 40.45±43.71 0.11
Salty snacks 21.11±27.86 17.98±17.80 0.67
Sweet snacks 43.19±51.30 30.61±25.52 0.03
*Mean daily intake of food groups (grams/day) ± Standard deviation
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Table 4: Odds ratio and 95% confidence interval for the association of food group intake and multiple sclerosis *
Tertile categories of dietary intake(g/day)  Dietary intake(g/day)
 OR (95% CI)    OR(95% CI)
T1 T2 T3 P-value
Grains †70.7 81.7 98.7
Model1 ‡ 1 1.03(0.51-2.07) 1.00(0.49-2.01) 0.99(0.98-1.00) 0.54
Model2 § 1 0.75(0.23-2.39) 0.75(0.23-2.43) 0.98(0.94-1.01) 0.27
Total Dairy 27.8 43.6 67.6
Model1 1 1.03(0.51-2.07) 1.00(0.49-2.01) 0.98(0.97-0.99) 0.009
Model2 1 0.69(0.23-2.02) 2.05(0.61-6.81) 0.98(0.96-1.01) 0.3
Legumes 4.4 5.9 9.8
Model1 1 1.43(0.33-6.14) 1.34(0.45-4.03) 0.85(0.95-1.04) 0.99
Model2 1 0.74(0.23-2.36) 0.74(0.23-2.39) 0.99(0.91-1.09) 0.97
Meat (non-processed) 7.03 9.68 13.1
Model1 1 1.64(0.44-6.19) 2.35(0.54-10.34) 1.02(0.97-1.07) 0.28
Model2 1 1.23(0.44-3.47) 1.49(0.39-5.59) 1.38(1.13-1.68) 0.001
Processed Meat 0.449 0.913 2.11
Model1 1 1.11(0.23-3.87) 2.12(0.45-10.3) 1.25(1.03-1.51) 0.021
Model2 1 1.24(0.43-4.63) 1.42(0.43-4.63) 2.07(1.18-3.63) 0.01
Total Vegetables 38.3 52.2 75.1
Model1 1 0.78(0.36-2.94) 0.84(0.21-3.34) 1.01(0.99-1.02) 0.11
Model2 1 1.22(0.42-3.51) 1.33(0.36-4.92) 1.04(1.00-1.07) 0.01
Starchy vegetables 4.2 5.9 7.8
Model1 1 2.43(0.56-10.38) 3.34(0.83-11.65) 1.07(0.99-1.18) 0.12
Model2 1 1.83(0.59-5.64) 1.08(0.33-3.49) 1.17(0.97-1.41) 0.88
Fruits 45.5 56.9 83.1
Model1 1 1.33(0.31-3.23) 0.94(0.26-3.34) 0.99(0.99-1.00) 0.75
Model2 1 1.39(0.45-4.30) 1.00(0.21-4.43) 1(0.98_1.02) 0.66
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Nuts 0.11 0.99 2.09
Model1 1 1.12(0.33-4.23) 1.04(0.33-3.85) 0.93(0.90-1.04) 0.39
Model2 1 1.74(0.59-5.10) 1.04(0.30-3.61) 0.95(0.72-1.25) 0.72
Sugars 3.4 5.4 12.5
Model1 1 0.83(0.18-2.54) 3.65(0.54-16.23) 0.98(0.86-1.11) 0.8
Model2 1 0.54(0.16-1.82) 0.78(0.22-2.67) 1.01(0.81-1.26) 0.9
Oils 3.9 5.4 7.7
Model1 1 0.73(0.10-3.32) 0.63(0.15-3.66) 1.03(0.95-1.11) 0.47
Model2 1 0.26(0.07-0.96) 0.09(0.01-5) 0.75(0.6-0.93) 0.01
Salty snacks 1.2 1.9 3.3
Model1 1 1.32(0.32-4.89) 1.72(0.23-5.53) 0.94(0.82_1.07) 0.36
Model2 1 0.71(0.23-2.20) 0.63(0.17-2.23) 0.89(0.69-1.15) 0.38
Sweet snacks 2.1 3.6 6.5
Model1 1 0.84(0.24-4.23) 3.23(0.66-9.12) 0.91(0.84_0.99) 0.04
Model2 1 1.46(0.46-4.65) 4.76(1.22-18.61) 1.03(0.86-1.24) 0.71
* Multivariable logistic regression models were used with adjustment of potential confounders. 
† Median of intake of food group in each tertile category, used as a continuous variable in logistic regression 
models(10grams/day)
‡ Adjusted for energy(Kcal) 
§ Additional adjustment for Body mass index(BMI) (kg/m2), sex(male, female), family history of multiple 
sclerosis(yes, no) vitamin D supplementation before onset of disease(yes, no), city they lived in the first 15 
years of life(arid, humid, snow), total energy (kcal), total fibers(grams) and total fat (grams)
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Discussion
In this study, intake of different food groups and 
nutrients in MS patients and controls were evaluated. 
Our results suggest that the consumption of 
different kinds of meat is associated with increased 
risk of MS, supported by several epidemiological 
studies (20, 21). Other case-control studies have 
similarly illustrated that consumption of meat is 
positively associated with MS (22-25). In contrast, 
a case-control study of 226 women in Ahvaz, Iran 
revealed no association between the total amount of 
consumed meat and the risk of MS (26). However, 
the limited number of questions in a self-made 
questionnaire with no previous reliability check 
was perhaps inappropriate in this study.
Several mechanisms have been proposed to explain 
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 Figure 1. Study fellow chart
the association between meat intake and MS risk. 
Firstly, red meat is a source of N-glycolylneuraminic 
acid (Neu5Gc), which is a sialic acid not originally 
made in the human body. This molecule found 
in meat could be related to chronic inflammation 
as there are anti Neu5Gc antibodies found in the 
human body (27). Secondly, the effect of meat 
can be related to saturated animal fat it contains. 
Saturated fats can lead to obstruction of small 
capillaries. Moreover, the effect of fat on the cells 
occurs at the level of gene expression and cell 
growth and differentiation, which could be the 
cause of chronic inflammation (28, 29). Finally, the 
role of meat in increasing the risk of MS could be 
due to consumption of amines and nitrosoamines in 
red meat (especially processed meat) that facilitate 
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the formation of endogenous nitroso-compounds 
(NOCs). Formation of NOCs in the body is directly 
related to the amount of meat consumed. NOCs are 
mutagenic and could cause damage to DNA, thus 
consumption of processed meat can increase MS 
risk (30).
Role of diet and lifestyle on MS is still controversial 
and they are not considered as a part of the 
therapeutic approach in MS patients. However, 
nutritional factors and lifestyle modification 
might have an alleviating or aggregating role in 
MS, caused by the metabolic and inflammatory 
pathways inside cells. Specific diet can drive 
cells to produce pro-inflammatory molecules. The 
western high-calorie diet consisting of high salt, 
high fat, red meat, sugar-sweetened beverages, 
fried food, low fiber and insufficient physical 
activity are the factors leading to inflammation (4). 
Consumption of different food groups in western 
diet consisted of meat, processed meat, sweets 
and deserts has shown a positive correlation with 
inflammatory markers in serum (31). In addition, 
consumption of foods with higher inflammatory 
index (proinflammatory) was associated with 
increased risk of MS (32). In accordance with 
the findings on proinflammatory pathways of 
foods, proper nutritional intervention has been 
recommended for MS patients (32).
Lower intake of lycopene in MS patients compared 
to the control group was found in this study that 
warrants broader studies to characterize a temporal 
relationship. Lycopene is a carotenoid found 
in tomato, carrot, watermelon and some other 
fruits and vegetables with antioxidant and anti-
inflammatory effects (25). Neurons are sensitive to 
oxidative stress due to high consumption of oxygen 
as the neuronal membrane contains high amounts 
of polyunsaturated fatty acids that do not have a 
strong anti-oxidant effect (33). As oxygen radicals 
are observed in high amounts in the brain of people 
with neurodegenerative diseases, reactive oxygen 
species (ROS) might have a significant role (34, 
35). Although ROS might not be the main factor, 
they are likely to exacerbate disease progression 
through the oxidative damage and interaction with 
mitochondria (35). ROS are chemically reactive 
molecules naturally generated in biological 
systems known for having a role in cell survival, 
stress responses and mediating cellular activity 
such as inflammation (36). Brain white matter had 
a lower anti-oxidant activity and thus was more 
sensitive to damage from free oxygen radicals 
(24). Hypothetically, significantly lower intake 
of lycopene in MS patients in our study lead to 
decreased anti-oxidant and anti-inflammatory 
effects of lycopene as a protective factor in MS, 
though further studies are required. In contrast, no 
associations between intake of dietary carotenoids 
and risk of MS were reported in a large cohort 
study (37).
There are several points considered as strengths 
of our study. To our knowledge, limited studies 
have examined dietary factors related to MS risk. 
Evaluating food groups’ intake and micronutrient 
intake at the same time while comparing them 
between MS patients and control groups is a unique 
feature of this study. Our study was carried out in 
Tehran which is among the cities with the highest 
rate of MS in Iran (38). Moreover, we were able to 
conduct the study in a province with a high point 
prevalence of MS (39). 
Our study has several limitations. Although the 
inclusion criteria in this study were that patients 
should not have changed their diet since the 
diagnosis of the disease, the participants might have 
not completely reported minor diet alterations due 
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to recall bias. In order to decrease this effect, we 
used a validated food frequency questionnaire, with 
which the outcome was compared to several daily 
recalls in a previous study (17). Although small 
sample size and case-control sets are considered as 
weaknesses of the current study, use of a validated 
semi-quantitative FFQ for dietary assessment and 
use of several statistical models with adjustment of 
potential confounding variables were the strengths 
of this study.
In conclusion, a positive association was found 
between dietary intake of processed and non-
processed meat with the risk of multiple sclerosis 
in the patients of our study.
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